| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 92 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 92 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 92 |
| 3 | CYTARABINE | 71 |
| 4 | METHOTREXATE SODIUM | 68 |
| 5 | METHOTREXATE | 65 |
| 6 | DEXAMETHASONE | 60 |
| 7 | DEXAMETHASONE 1.5 MG | 60 |
| 8 | FLUDARABINE PHOSPHATE | 53 |
| 9 | CARBOPLATIN | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALASPARGASE PEGOL | 8 | 0.0100 |
| 1 | PEGFILGRASTIM-BMEZ | 4 | 0.0066 |
| 2 | RYDAPT | 11 | 0.0056 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0055 |
| 4 | GLOFITAMAB | 9 | 0.0033 |
| 5 | GEMTUZUMAB OZOGAMICIN | 10 | 0.0027 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 6 | 0.0025 |
| 7 | ZONISAMIDE | 23 | 0.0021 |
| 8 | THIOTEPA | 19 | 0.0019 |
| 9 | BUSULFAN | 30 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 123 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 108 |
| 2 | Corticosteroid [EPC] | 95 |
| 3 | Platinum-based Drug [EPC] | 76 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 70 |
| 5 | Topoisomerase Inhibitor [EPC] | 45 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 43 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 37 |
| 8 | Benzodiazepine [EPC] | 34 |
| 9 | BCL-2 Inhibitor [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 10 | 0.0027 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 6 | 0.0025 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 9 | 0.0022 |
| 3 | CD30-directed Immunoconjugate [EPC] | 19 | 0.0018 |
| 4 | Asparagine-specific Enzyme [EPC] | 18 | 0.0013 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 9 | 0.0009 |
| 6 | Antimalarial [EPC] | 8 | 0.0008 |
| 7 | Antiprotozoal [EPC] | 8 | 0.0008 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 12 | 0.0007 |
| 9 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |